Professional
Added to YB: 2025-05-26
Pitch date: 2025-03-31
TEVA [neutral]
Teva Pharmaceutical Industries Limited
+68.01%
current return
Author Info
No bio for this author
Company Info
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
Market Cap
$30.7B
Pitch Price
$57.08
Price Target
N/A
Dividend
N/A
EV/EBITDA
9.65
P/E
43.30
EV/Sales
2.72
Sector
Pharmaceuticals
Category
turnaround
The Sound Shore Fund Added On Portfolio Holding: Teva Pharmaceutical Industries Limited
TEVA (increased position): Generic/specialty pharma focused on neuro/respiratory. Invested at 4x earnings, 20%+ FCF yield after poor capital allocation. New leadership improved margins via execution & pipeline dev. Added to position on recent price weakness. Remains remarkably cheap.
Read full article (1 min)